Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils

Clinical and Experimental Immunology

Volumn 136, Issue 2, 2004, Pages 255-261

  Steel, H C ^a,b   Anderson, R ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b Department of Immunology ^*  (South Africa)

Author keywords

Calcium; Chemoattractants; Itraconazole; Neutrophils

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIFUNGAL AGENT; CHEMOATTRACTANT; CYCLIC AMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INOSITOL TRISPHOSPHATE; ITRACONAZOLE; THROMBOCYTE ACTIVATING FACTOR;

ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL MEMBRANE; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; GRANULOMATOSIS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LEUKOCYTE ACTIVATION; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; RADIOMETRY; SPECTROFLUOROMETRY;

ANTIFUNGAL AGENTS; BIOLOGICAL TRANSPORT, ACTIVE; CALCIUM; CALCIUM CHANNELS; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; CYTOSOL; HUMANS; ITRACONAZOLE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; PLATELET ACTIVATING FACTOR; SPECTROMETRY, FLUORESCENCE;

EID: 2142812482     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02443.x     Document Type: Article

References (38)

1. Cale CM, Jones AM, Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 2000; 120:351-5.
2. Gallin JI, Alling DW, Malech HL et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003; 348:2416-22.
3. Bohme A, Justnubling G, Bermann L, Shah PM, Stille W, Hoelzer D. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies. J Antimicrob Chemother 1996; 38:953-61.
4. Lamy T, Bernard M, Courois A et al. Prophylactic use of itraconazole for the prevention of invasive pulmonary aspergillosis in high risk neutropenic patients. Leuk Lymphoma 1998; 30:163-74.
5. Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia. J Peirodontol 2002; 73:33-8.
6. Goldman M, Cloud GA, Smedema M et al. Does long-term itraconazole prophylaxis result in in vitro resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection? Antimicrob Agents Chemother 2000; 44:1585-7.
7. McKinsey DS, Wheat LJ, Cloud GA et al. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized placebo-controlled, double-blind study. Clin Infect Dis 1999; 28:1049-56.
8. Kramer MR, Menin G, Rudis E et al. Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). Transplant Proc 1997; 29:2657-9.
9. 2+ influx: what is the message from the stores to the membrane? J Laboratory Clin Med 1996; 128:19-26.
10. 2+ permeability by imidazole antimycotics. Immunopharmacol Immunotoxicol 1996; 18:237-45.
11. Tran Q-M, Ohashi K, Watanabe H. Calcium signalling in endothelial cells. Cardiovasc Res 2000; 48:13-22.
12. 2+ stores. Biochem J 1991; 277:73-9.
13. Anderson R, Goolam Mahomed A. Calcium efflux and influx in f-met-leu-phe (fMLP) -activated human neutrophils are chronologically distinct events. Clin Exp Immunol 1997; 110:132-8.
14. 2+ controls time not space. J Cell Sci 2003; 116:2857-65.
15. 2+. Am J Respir Cell Mol Biol 2003; 28:713-21.
16. Tintinger GR, Theron AJ, Steel HC, Anderson R. Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease. Clin Exp Immunol 2001; 123:254-63.
17. Rada BK, Geiszt M, Van Bruggen R, Német K, Roos D, Ligeti E. Calcium signaling is altered in myeloid cells with a deficiency in NADPH oxidase activity. Clin Exp Immunol 2003; 132:53-60.
18. Theron AJ, Steel HC, Tintinger GR, Anderson R. Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium. Inflamm Res 2002; 51:594-602.
19. Broad LM, Braun F-J, Lievremont J-P, Bird GSJ, Kurosaki T, Putney JW. Role of the phospholipase C-inositol 1,4,5-triphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J Biol Chem 2001; 276:15945-52.
20. Ma H-T, Venkatachalam K, Parys JB, Gill DL. Modification of store-operated channel coupling and inositol triphosphate receptor function by 2-aminoethoxydiphenyl borate in DT40 lymphocytes. J Biol Chem 2002; 277:6915-22.
21. Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J Biol Chem 1991; 266:17067-71.
22. Steel HC, Anderson R. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium. Br J Pharmacol 2002; 136:81-9.
23. Holmsen HE, Storm E, Day HJ. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1972; 46:481-501.
24. Alonso-Torres SR, Garcia-Sancho J. Arachidonic acid inhibits capacitative calcium entry in rat thymocytes and human neutrophils. Biochem Biophys Acta 1997; 1328:207-13.
25. Wang JS, Wen X, Backman JT, Taavitsainen P, Neuvonen PJ, Kivist KT. Midazolem alpha-hydroxylation by human liver microsomes in vitro: inhibition by calcium blockers, itraconazole and ketoconazole. Pharmacol Toxicol 1999; 85:157-61.
26. Nick JA, Avdi NJ, Young SK et al. Common and distinct intracellular signalling pathways in human neutrophils utilized by platelet activating factor and FMLP. J Clin Invest 1997; 99:975-86.
27. Ali H, Sozzani S, Fisher I et al. Differential regulation of formyl peptide and platelet activating factor receptors: Role of phospholipase Cβ3 phosphorylation by protein kinase A. J Biol Chem 1998; 273:11012-6.
28. 2+ influx in human neutrophil granulocytes: alterations in chronic granulomatous disease. J Biol Chem 1997; 272:26471-8.
29. Hallett MB. Holding back neutrophil aggression; the oxidase has potential. Clin Exp Immunol 2003; 132:181-4.
30. Anderson R, Goolam Mahomed A, Theron AJ, Ramafi G, Feldman C. Effects of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils. Br J Pharmacol 1998; 124:547-55.
31. Itagaki K, Kannan KB, Livingston DH, Deitch EA, Fekete Z, Hauser CJ. Store-operated calcium entry in human neutrophils reflects multiple contributions from independently regulated pathways. J Immunol 2002; 168:4063-9.
32. Yasui K, Masuda M, Matsuoka T et al. Miconazole and amphotericin B alter polymorphonuclear leukocyte functions and membrane fluidity in similar fashions. Antimicrob Agents Chemother 1988; 32:1864-8.
33. Goolam Mahomed A, Anderson R. Activation of human neutrophils with chemotactic peptide, opsonized zymosan and the calcium ionophore A23187, but not with a phorbol ester, is accompanied by efflux and store-operated influx of calcium. Inflammation 2000; 24:559-69.
34. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine 2000; 79:170-200.
35. Warris A, Netea MG, Wang JE et al. Cytokine release in healthy donors and patients with chronic granulomatous disease upon stimulation with Aspergillus fumigatus. Scand J Infect Dis 2003; 35:482-7.
36. Tsuji S, Taniuchi S, Hasui M, Yamamoto A, Kobayashi Y. Increased nitric oxide production by neutrophils from patients with chronic granulomatous disease on trimethoprim-sulfamethoxazole. Nitric Oxide 2002; 7:283-8.
37. Vogeser M, Spohrer U, Schiel X. Determination of itraconazole and hydroxyitra-conazole in plasma by use of liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Clin Chem Laboratory Med 2003; 41:915-20.
38. Wark PA, Hensley MJ, Saltos N et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: a randomized controlled trial. J Allergy Clin Immunol 2003; 111:952-7.